Progress in Therapy of Lung Cancer

Lung cancer has become one of the most common cancers worldwide, and it is also the main cause of cancer-related deaths. It is estimated that over 22 million new cases and 1.79 million deaths are caused by lung cancer each year. The theory of "airway field of injury" has been used to explain the pathogenesis of lung cancer, but its specific molecular mechanism is not clear yet. With the completion of comprehensive genomic analysis of lung cancer, modern medicine has revealed its genetic heterogeneity and complexity, and identified many oncogenic driving genes and molecular pathogenesis of lung cancer. At present, common treatment methods for lung cancer include chemotherapy, radiotherapy, targeted therapy, immunotherapy, and gene therapy. Each treatment has a unique mechanism and targets, but also has different advantages and disadvantages. Corresponding to different lung cancer patients, it is necessary to comprehensively consider their physiological health and economic status, choosing appropriate treatment strategies.